Tumour profile tests offer some hope to cancer patients
Studies have found them promising but further investigation is needed
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Washington
WHEN Jen Morey was diagnosed with colon cancer in June 2013, her oncologist began treating her with a chemotherapy usually prescribed for that type of cancer. But after a couple of months, the malignancy was still growing, and rapidly. The therapy was failing.
So her doctor ordered a test to identify aspects of the tumour's genetic make-up that might be fuelling its growth.
Share with us your feedback on BT's products and services
TRENDING NOW
Vietnam formalises new state leadership, redefining ‘four pillars’ power balance
‘Largest Singapore commercial S-Reit proxy’: analysts say buy CICT shares after Paragon acquisition
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
